Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Sandoz sells antibodies & patents to Protein Design

Executive Summary

Sandoz sold to Protein Design Labs four human antiviral antibodies for $4.5 million and a 90% humanized anti-tumor antibody with its mouse progenitor (SMART ABL 364 and ABL 364) for $500,000. PDL will pay up to $5 million more based on milestones.
Deal Industry
  • Biotechnology
    • Large Molecule
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing
    • Co-Marketing
    • Co-Promotion
    • Includes Royalty or Profit Split Information

Related Companies